MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Attovia Therapeutics, Inc. (ATTO)

Attovia Therapeutics, Inc. (ATTO)

||
||

Balance Sheets Overview

Current Ratio
938.57%
Quick Ratio
938.57%
Cash Ratio
260.24%
Debt to Asset Ratio
12.14%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Redeemable convertible preferred...
    • Accumulated deficit
    • Accounts payable (including rela...
    • Others
Balance Sheets
2026-06-30
Cash and cash equivalents
32,829
Marketable securities
82,303
Prepaid expenses and other current assets
3,269
Total current assets
118,401
Restricted cash
404
Property, plant, and equipment gross
4,928
Less accumulated depreciation
1,585
Property and equipment, net
3,343
Operating lease right-of-use asset, net
3,578
Other non-current assets
2,622
Total assets
128,348
Accounts payable (including related party amounts of 32 and 39 at june, 2026 and december 31, 2025, respectively)
6,002
Accrued expenses and other current liabilities
4,575
Operating lease liability, current portion
2,038
Total current liabilities
12,615
Operating lease liability, net of current portion
2,288
Other non-current liabilities
678
Total liabilities
15,581
Redeemable convertible preferred stock - 0.0001 par value 199,902,270 shares authorized, issued and outstanding at june 30, 2026 and december 31, 2025 aggregate liquidation preference of 255,850 at june 30, 2026 and december 31, 2025
258,226
Common stock - 0.0001 par value 284,023,000 shares authorized at june 30, 2026 and december 31, 2025 4,529,100 and 4,507,108 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
1
Additional paid-in capital
4,972
Accumulated other comprehensive (loss) income
-79
Accumulated deficit
-150,353
Total stockholders' deficit
-145,459
Total liabilities, redeemable convertible preferred stock, and stockholders' deficit
128,348
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$82,303K Cash and cashequivalents$32,829K Prepaid expenses andother current assets$3,269K Property, plant, andequipment gross$4,928K Total current assets$118,401K Operating leaseright-of-use asset, net$3,578K Property and equipment,net$3,343K Other non-currentassets$2,622K Restricted cash$404K Less accumulateddepreciation$1,585K Total assets$128,348K Accumulated deficit-$150,353K Accumulated othercomprehensive (loss) income-$79K Total liabilities,redeemable convertible...$128,348K Total stockholders'deficit-$145,459K Additional paid-in capital$4,972K Common stock - 0.0001par value...$1K Redeemable convertiblepreferred stock - 0.0001...$258,226K Total liabilities$15,581K Total currentliabilities$12,615K Operating leaseliability, net of current...$2,288K Other non-currentliabilities$678K Accounts payable(including related party...$6,002K Accrued expenses andother current...$4,575K Operating leaseliability, current portion$2,038K